v3.24.0.1
SHAREHOLDERS' EQUITY AND SHARE OWNERSHIP AND RIGHTS - Share Capital (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 24, 2023
USD ($)
$ / shares
shares
Aug. 09, 2022
USD ($)
$ / shares
shares
Mar. 31, 2023
shares
Sep. 30, 2022
$ / shares
shares
Sep. 30, 2023
Y
Vote
$ / shares
shares
Dec. 31, 2022
Y
Vote
$ / shares
shares
Oct. 26, 2023
$ / shares
shares
Nov. 03, 2022
$ / shares
shares
Nov. 02, 2022
shares
Aug. 02, 2022
$ / shares
Aug. 01, 2022
shares
Jul. 14, 2022
$ / shares
Apr. 22, 2022
shares
Apr. 12, 2022
$ / shares
shares
Apr. 11, 2022
shares
Dec. 31, 2021
$ / shares
shares
SHAREHOLDERS' EQUITY                                
Ordinary shares, shares authorized         8,333,334 8,333,334 100,000,000 8,333,334 833,334         833,334   8,333,334
Ordinary shares, par value | $ / shares         $ 0 $ 0 $ 0 $ 0           $ 0   $ 0
Number of vote for each ordinary share | Vote         1 1                    
Number of years of income that limits distribution | Y         2                      
Maximum period between date of financial statements and distribution date         6 months                      
Threshold period for not to issue or proposed issuance of any ADSs or ordinary shares 90 days 90 days                            
Threshold period for not to enter in to an agreement for variable rate transaction from the date of closing of the Offering 180 days 180 days                            
Quoin Pharmaceuticals Inc                                
SHAREHOLDERS' EQUITY                                
Ordinary shares, shares authorized               8,333,334 833,334         833,334 208,334  
Ordinary shares, par value | $ / shares               $ 0           $ 0    
Number of years of income that limits distribution | Y           2                    
Maximum period between date of financial statements and distribution date           6 months                    
Warrant Amendments                                
SHAREHOLDERS' EQUITY                                
Incremental fair value | $ $ 238,000                              
Minimum [Member]                                
SHAREHOLDERS' EQUITY                                
Warrants, exercise price of warrants (in dollars per share) | $ / shares $ 13.20                     $ 0        
Maximum [Member]                                
SHAREHOLDERS' EQUITY                                
Warrants, exercise price of warrants (in dollars per share) | $ / shares $ 60.00                     $ 597        
Public offering                                
SHAREHOLDERS' EQUITY                                
Issuance of ADS and Pre-Funded Warrants, net (in shares) 412,500 184,167                            
Public offering | Pre-Funded Warrants                                
SHAREHOLDERS' EQUITY                                
Warrants, number of securities called by warrants (in shares) 170,833 95,833                            
ADS                                
SHAREHOLDERS' EQUITY                                
Issuance of ADS and Pre-Funded Warrants, net (in shares)     583,333 280,000                        
Warrants, number of securities called by warrants (in shares)                         1.0      
Warrants, exercise price of warrants (in dollars per share) | $ / shares $ 60.00     $ 0.00           $ 0.00            
Shares warrants may purchase 280,000                       28,508      
Number of ordinary shares for ADS                     5,000          
ADS | Quoin Pharmaceuticals Inc                                
SHAREHOLDERS' EQUITY                                
Number of ordinary shares for ADS           5,000                    
ADS | Warrant Amendments                                
SHAREHOLDERS' EQUITY                                
Warrants, exercise price of warrants (in dollars per share) | $ / shares $ 13.20                              
Shares warrants may purchase 236,670                              
ADS | Public offering                                
SHAREHOLDERS' EQUITY                                
Issuance of ADS and Pre-Funded Warrants, net (in shares) 412,500                              
Purchase price | $ / shares $ 12.00 $ 60.00                            
ADS | Public offering | Quoin Pharmaceuticals Inc                                
SHAREHOLDERS' EQUITY                                
Issuance of ADS and Pre-Funded Warrants, net (in shares)   184,167                            
ADS | Public offering | Pre-Funded Warrants                                
SHAREHOLDERS' EQUITY                                
Purchase price | $ / shares $ 11.9988 $ 59.998                            
Warrants, number of securities called by warrants (in shares) 170,833 95,833                            
Gross proceeds from offering | $ $ 7,000,000.0 $ 16,800,000                            
Net proceeds from offering | $ $ 5,800,000 $ 14,900,000                            
Warrants, exercise price of warrants (in dollars per share) | $ / shares   $ 60.00                            
ADS | Public offering | Common Warrants                                
SHAREHOLDERS' EQUITY                                
Warrants, exercise price of warrants (in dollars per share) | $ / shares $ 12.00